APUS Apimeds Pharmaceuticals US, Inc.

BEARISH Impact: 7/10 8-K
Horizon weeks Filed May 4, 2026 Processed 1mo ago SEC 0001213900-26-051125
8-K material event: Items 1.01
Latest settled — T+20d
APUS ▼ -19.15% at T+20d
SHORT call ✓ call won +19.15% · α vs SPY +24.79% · entry $1.88 → $1.52
Next anchor: T+60d in 7w
Currently $1.28 · +31.91% from $1.88 entry (call sign-flipped)
Entry anchored
May 4, 2026
via day open
T+1d
+59.57%
call -59.57% · α -58.78%
$3.00
settled 6w ago
T+5d
-22.34%
call +22.34% · α +25.28%
$1.46
settled 5w ago
T+20d
-19.15%
call +19.15% · α +24.79%
$1.52
settled 11d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

APUS filed an 8-K detailing a comprehensive settlement resolving shareholder disputes and a forbearance agreement with its $11M noteholder. The company's stock remains halted on NYSE American, and it faces a June 30, 2026 deadline to regain listing compliance. Lokahi will contribute $4M in working capital and forgive $750k in advances, but the company is under intense operational and regulatory pressure.

Actionable Insight

Monitor APUS for filing of 10-K and NYSE listing application. Stock remains halted; any delays in meeting forbearance conditions could trigger default. The settlement reduces immediate governance risk but does not address fundamental liquidity or operating performance.

Key Facts

  • Settlement resolves disputes among APUS, MindWave, Lokahi, and Inscobee; Inscobee grants irrevocable proxy to management.
  • Lokahi to transfer $4M working capital to APUS/Newco by April 29, 2026, and forgive $750k advance.
  • APUS enters forbearance with Alto Opportunity Master Fund on $11M convertible note; conditions include filing 10-K by April 30, 2026 and regaining NYSE compliance by June 30, 2026.
  • Stock trading halted on NYSE American; company must obtain listing approval, effect 1-for-10 reverse stock split, and resume trading by June 30, 2026.
  • Board transitions: interim board of three directors, then three new independent directors appointed by Inscobee subject to Menon's approval.
  • Newco to be formed as wholly owned subsidiary, to be spun off within 12 months; 90% of net financing proceeds go to MindWave, 10% to Newco.
  • Emerson files to dismiss lawsuit against Inscobee; mutual releases among parties.

Financial Impact

Lokahi contributes $4M working capital; note principal $11M; total cash inflow $4M offset by $750k forgiveness.

debtcashdilution

Risk Factors

  • Failure to meet forbearance conditions could trigger note acceleration and default.
  • NYSE delisting if listing application is denied or compliance not regained by June 30, 2026.
  • Uncertainty over Newco spin-off and valuation.
  • Potential dilution from preferred stock conversion and note conversion.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-051125
Document: ea0288393-8k_apimeds.htm0001213900-26-051125
Document: ea028839301ex10-3.htm0001213900-26-051125
Document: ea028839301ex10-2.htm0001213900-26-051125
Document: 0001213900-26-051125-index-headers.html0001213900-26-051125
Document: 0001213900-26-051125-index.html0001213900-26-051125
Document: 0001213900-26-051125.txt0001213900-26-051125
3 reports for APUS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for APUS — sortable, filterable
Type Now
May 5, 2026
5w ago
8-K
NEUTRAL ★ 2/10
$3.00 $1.32▼ −56.00%▼ −60.95%$1.28 (−57.33%)
May 4, 2026
5w ago
8-K
BEARISH ★ 7/10
$1.88 $1.52▲ +19.15%▲ +24.79%$1.28 (+31.91%)
Apr 16, 2026
8w ago
8-K
BEARISH ★ 7/10
$1.88 $1.37▲ +27.13%▲ +32.50%$1.28 (+31.91%)
Showing 3 of 3

US Market Status

Market Closed — Opens Mon (48h 50m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access